β -blockers’ neuropsychiatric risks: Overlooked evidence?

Abstract

Get full access to this article

View all access options for this article.

References

Ez Eddin

Omrani

Chalabianloo

, et al. (2025) β-blockers and risk of neuropsychiatric adverse events: An active-comparator restricted disproportionality on the FAERS. Journal of Psychopharmacology. Epub ahead of print 24 July 2025. DOI: 10.1177/02698811251349190.

Goldman

(1998) Limitations and strengths of spontaneous reports data. Clinical Therapeutics 20(Suppl C): C40–C44.

Liu

(2025) β-blockers’ neuropsychiatric risks: Overlooked evidence? Journalof Psychopharmacology. Manuscript submitted for publication.